100 related articles for article (PubMed ID: 30253213)
1. Binding and structure-kinetic relationship analysis of selective TLR4-targeted immunosuppressive self-assembling heparin nanoparticles.
Babazada H; Yanamoto S; Hashida M; Yamashita F
Int J Pharm; 2018 Dec; 552(1-2):76-83. PubMed ID: 30253213
[TBL] [Abstract][Full Text] [Related]
2. Self-assembling lipid modified glycol-split heparin nanoparticles suppress lipopolysaccharide-induced inflammation through TLR4-NF-κB signaling.
Babazada H; Yamashita F; Yanamoto S; Hashida M
J Control Release; 2014 Nov; 194():332-40. PubMed ID: 25234820
[TBL] [Abstract][Full Text] [Related]
3. Suppression of experimental arthritis with self-assembling glycol-split heparin nanoparticles via inhibition of TLR4-NF-κB signaling.
Babazada H; Yamashita F; Hashida M
J Control Release; 2014 Nov; 194():295-300. PubMed ID: 25242730
[TBL] [Abstract][Full Text] [Related]
4. MD2 mediates angiotensin II-induced cardiac inflammation and remodeling via directly binding to Ang II and activating TLR4/NF-κB signaling pathway.
Han J; Zou C; Mei L; Zhang Y; Qian Y; You S; Pan Y; Xu Z; Bai B; Huang W; Liang G
Basic Res Cardiol; 2017 Jan; 112(1):9. PubMed ID: 28013347
[TBL] [Abstract][Full Text] [Related]
5. Lipopolysaccharide (LPS) directly suppresses growth hormone receptor (GHR) expression through MyD88-dependent and -independent Toll-like receptor-4/MD2 complex signaling pathways.
Dejkhamron P; Thimmarayappa J; Kotlyarevska K; Sun J; Lu C; Bonkowski EL; Denson LA; Menon RK
Mol Cell Endocrinol; 2007 Aug; 274(1-2):35-42. PubMed ID: 17601656
[TBL] [Abstract][Full Text] [Related]
6. [Bacterial endotoxin-induced endothelial cell injury and calcium overload associated with Toll-like receptor and calcium signal].
Xiao J; Song Q; Li T; Sun R
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Feb; 29(2):150-155. PubMed ID: 28625263
[TBL] [Abstract][Full Text] [Related]
7. TAK-242 selectively suppresses Toll-like receptor 4-signaling mediated by the intracellular domain.
Kawamoto T; Ii M; Kitazaki T; Iizawa Y; Kimura H
Eur J Pharmacol; 2008 Apr; 584(1):40-8. PubMed ID: 18299127
[TBL] [Abstract][Full Text] [Related]
8. Soyasaponin Bb inhibits the recruitment of toll-like receptor 4 (TLR4) into lipid rafts and its signaling pathway by suppressing the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase-dependent generation of reactive oxygen species.
Zhang Y; Chen F; Chen J; Huang S; Chen J; Huang J; Li N; Sun S; Chu X; Zha L
Mol Nutr Food Res; 2016 Jul; 60(7):1532-43. PubMed ID: 27005845
[TBL] [Abstract][Full Text] [Related]
9. TLR4/MD2 specific peptides stalled in vivo LPS-induced immune exacerbation.
Park S; Shin HJ; Shah M; Cho HY; Anwar MA; Achek A; Kwon HK; Lee B; Yoo TH; Choi S
Biomaterials; 2017 May; 126():49-60. PubMed ID: 28254693
[TBL] [Abstract][Full Text] [Related]
10. Discovery of new MD2 inhibitor from chalcone derivatives with anti-inflammatory effects in LPS-induced acute lung injury.
Zhang Y; Wu J; Ying S; Chen G; Wu B; Xu T; Liu Z; Liu X; Huang L; Shan X; Dai Y; Liang G
Sci Rep; 2016 Apr; 6():25130. PubMed ID: 27118147
[TBL] [Abstract][Full Text] [Related]
11. Curcumin Analog L48H37 Prevents Lipopolysaccharide-Induced TLR4 Signaling Pathway Activation and Sepsis via Targeting MD2.
Wang Y; Shan X; Dai Y; Jiang L; Chen G; Zhang Y; Wang Z; Dong L; Wu J; Guo G; Liang G
J Pharmacol Exp Ther; 2015 Jun; 353(3):539-50. PubMed ID: 25862641
[TBL] [Abstract][Full Text] [Related]
12. Key residues in TLR4-MD2 tetramer formation identified by free energy simulations.
Tafazzol A; Duan Y
PLoS Comput Biol; 2019 Oct; 15(10):e1007228. PubMed ID: 31609969
[TBL] [Abstract][Full Text] [Related]
13. Lipid A from lipopolysaccharide recognition: structure, dynamics and cooperativity by molecular dynamics simulations.
Garate JA; Oostenbrink C
Proteins; 2013 Apr; 81(4):658-74. PubMed ID: 23184816
[TBL] [Abstract][Full Text] [Related]
14. Candida albicans-derived mannoproteins activate NF-κB in reporter cells expressing TLR4, MD2 and CD14.
Ness T; Abdallah M; Adams J; Alvarado C; Gunn E; House B; Lamb J; Macguire J; Norris E; Robinson R; Sapp M; Sharma J; Garner R
PLoS One; 2017; 12(12):e0189939. PubMed ID: 29281684
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationship study of dihydroartemisinin C-10 hemiacetal derivatives as Toll-like receptor 4 antagonists.
Wang S; Wang H; Lin C; Zhang T; Gao J; Wu S; Wang Y; Li H; Min W; Liu C; Wang X
Bioorg Chem; 2021 Sep; 114():105107. PubMed ID: 34175717
[TBL] [Abstract][Full Text] [Related]
16. Intracellular expression of toll-like receptor 4 in neuroblastoma cells and their unresponsiveness to lipopolysaccharide.
Hassan F; Islam S; Tumurkhuu G; Naiki Y; Koide N; Mori I; Yoshida T; Yokochi T
BMC Cancer; 2006 Dec; 6():281. PubMed ID: 17156435
[TBL] [Abstract][Full Text] [Related]
17. The molecular mechanisms of the effect of Dexamethasone and Cyclosporin A on TLR4 /NF-κB signaling pathway activation in oral lichen planus.
Ge Y; Xu Y; Sun W; Man Z; Zhu L; Xia X; Zhao L; Zhao Y; Wang X
Gene; 2012 Oct; 508(2):157-64. PubMed ID: 22903029
[TBL] [Abstract][Full Text] [Related]
18. Endotoxin-Binding Peptides Derived from Casein Glycomacropeptide Inhibit Lipopolysaccharide-Stimulated Inflammatory Responses via Blockade of NF-κB activation in macrophages.
Cheng X; Gao D; Chen B; Mao X
Nutrients; 2015 Apr; 7(5):3119-37. PubMed ID: 25923657
[TBL] [Abstract][Full Text] [Related]
19. Emodin ameliorated lipopolysaccharide-induced fulminant hepatic failure by blockade of TLR4/MD2 complex expression in D-galactosamine-sensitized mice.
Yin X; Gong X; Jiang R; Kuang G; Wang B; Zhang L; Xu G; Wan J
Int Immunopharmacol; 2014 Nov; 23(1):66-72. PubMed ID: 25173984
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of alternaramide on inflammatory mediator expression through TLR4-MyD88-mediated inhibition of NF-кB and MAPK pathway signaling in lipopolysaccharide-stimulated RAW264.7 and BV2 cells.
Ko W; Sohn JH; Jang JH; Ahn JS; Kang DG; Lee HS; Kim JS; Kim YC; Oh H
Chem Biol Interact; 2016 Jan; 244():16-26. PubMed ID: 26620692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
